查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
CRISPR 技术的全球市场
市场调查报告书
商品编码
1184203

CRISPR 技术的全球市场

CRISPR Technology: Global Markets
出版日期: | 出版商: BCC Research | 英文 131 Pages | 订单完成后即时交付

价格

全球 CRISPR 技术市场规模预计将从 2022 年的 33 亿美元增长到 2027 年的 92 亿美元，2022 年至 2027 年的复合年增长率为 22.3%。

生物技术和製药行业预计将从 2022 年的 26 亿美元增长到 2027 年的 73 亿美元，2022 年至 2027 年的复合年增长率为 22.1%。 此外，学术和政府研究机构部门预计将从 2022 年的 3.716 亿美元增长到 2027 年的 10 亿美元，复合年增长率为 23.5%。

在本报告中，我们调查了全球 CRISPR 技术市场，提供了市场概况、影响市场增长的各种因素的分析、市场规模的趋势和预测、每个细分市场、地区/主要国家和竞争的详细分析. 总结大环境、大公司概况等。

内容

第一章介绍

第 2 章要点摘要

第 3 章市场概述

  • CRISPR：基因编辑
  • CRISPR-Cas 系统的组成部分
    • SgRNA
    • Cas9核酸□
  • CRISPR-Cas 的工作原理
  • CRISPR-Cas9 系统的优势
  • CRISPR 基因组编辑的普及
  • 基因编辑的优势
  • CRISPR 的开发阶段
  • 市场潜力
  • 监管框架
  • 波特的五力分析
  • 科学出版物
  • 专利分析
  • CRISPR 的未来
  • 市场驱动力
  • 市场製约因素
  • 市场问题

第四章产业结构

  • 商业疗法
  • 纠正遗传错误
  • 微生物
  • 更健康的食物

第 5 章 COVID-19 对 CRISPR 技术市场的影响

第六章竞争格局

  • 概览
  • 竞争场景
  • Beam Therapeutics
  • CRISPR 疗法
  • Editas 医学
  • Intellia Therapeutics
  • 增长策略

第 7 章全球 CRISPR 技术市场：按最终用户分类

  • 市场概览
  • 市场份额/预测
  • 生物技术和製药公司
  • 学术和政府研究机构
  • 委託研究机构

第 8 章。全球 CRISPR 技术市场：按应用

  • 市场份额/预测
  • 药物开发
  • 农业
  • 诊断
    • 感染
    • 非传染性疾病
  • 临床治疗
  • 其他

第 9 章。全球 CRISPR 技术市场：按地区

  • 北美
  • 欧洲
  • 亚太地区
  • 其他地区

第十章公司简介

  • CARIBOU BIOSCIENCES
  • CRISPR THERAPEUTICS AG
  • DANAHER CORP.
  • EDITAS MEDICINE
  • GENSCRIPT
  • HERA BIOLABS
  • INTELLIA THERAPEUTICS INC.
  • LONZA GROUP LTD.
  • MAMMOTH BIOSCIENCES INC.
  • NEW ENGLAND BIOLABS INC.
  • ORIGENE TECHNOLOGIES
  • PERKINELMER
  • PRECISION BIOSCIENCES
  • SYNTHEGO
  • THERMO FISHER SCIENTIFIC
  • TOOLGEN INC.
Product Code: HLC258B

Highlights:

The global CRISPR Technology market reached $3.3 billion in 2022 and should reach $9.2 billion by 2027, with a compound annual growth rate (CAGR) of 22.3% during the forecast period of 2022-2027.

Biotechnology and pharmaceutical companies segment of the global CRISPR Technology market reached $2.6 billion in 2022 and should reach $7.3 billion by 2027, with a CAGR of 22.1% during the forecast period of 2022-2027.

Academics and government research institutes segment of the global CRISPR Technology market reached $371.6 million in 2022 and should reach $1 billion by 2027, with a CAGR of 23.5% during the forecast period of 2022-2027.

Report Scope:

The current report provides detailed exposure to the CRISPR technology market. This report highlights the current and future market potential of CRISPR technology, along with a detailed analysis of the drivers, restraints, and challenges in the market. The report also covers market projections for 2027, as well as the competitive environment and regulatory scenario. The report details the market share of CRISPR technology on applications and end users. The market is segmented into Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, and Contract Research Organizations (CROs) based on end users. The market is categorized as Drug Development, Agriculture, Diagnostics, Clinical therapy, and Others based on Application. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments. The report also discusses the impact of the COVID-19 pandemic on this market.

By geography, the market has been segregated into North America, Europe, Asia-Pacific, and the Rest of the world. The North American region includes countries such as the U.S. and Canada; Europe includes Germany, U.K., France, and the Rest of Europe; Asia-Pacific includes China, India, Japan, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2019 as the historic year, 2021 as the base year, and forecast for 2027.

Report Includes:

  • 17 data tables and 37 additional tables
  • An up-to-date overview and analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
  • Analyses of the global market trends, with historic revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the market potential for CRISPR technology, industry growth drivers, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and revenue forecast for the global CRISPR technology market in USD million terms, and corresponding market share analysis by application, end user, and region
  • Discussion of the major market dynamics, key shifts and regulations, industry specific challenges, and macroeconomic factors affecting the demand for CRISPR technology market over the coming years (2022-2027)
  • Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
  • A look at the recent technical breakthrough on the use of CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
  • Comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
  • Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
  • Insight into recent industry structure for CRISPR-Cas9 genome editing technology, competitive environment, clinical trials, ongoing research activities, and the COVID-19 impact on the marketplace
  • Company profiles of major players within the industry, including CRISPR Therapeutics AG, GenScript, Lonza Group Ltd, PerkinElmer and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

  • 1.1 Study Goals and Objectives
  • 1.2 Reasons for Doing This Study
  • 1.3 Intended Audience
  • 1.4 Scope of Report
  • 1.5 What's New in this Report?
  • 1.6 Information Sources
  • 1.7 Methodology
  • 1.8 Geographic Breakdown
  • 1.9 Analyst's Credentials
  • 1.10 BCC Custom Research
  • 1.11 Related BCC Research Reports

Chapter 2 Summary and Highlights

  • 2.1 Highlights of the Market for CRISPR Technology

Chapter 3 Market Overview

  • 3.1 CRISPR: Genetic Editing
  • 3.2 Components of CRISPR-Cas Systems
    • 3.2.1 SgRNA
    • 3.2.2 Cas9 Nucleases
  • 3.3 How CRISPR-Cas Works?
  • 3.4 Advantage of the CRISPR-Cas9 System
  • 3.5 Popularity of CRISPR Genome Editing
  • 3.6 Pros of Genetic Editing
  • 3.7 CRISPR Development Phases
    • 3.7.1 Discovery of CRISPR
    • 3.7.2 Discovery of Cas9 and PAM
    • 3.7.3 Hypothesis: Adaptive Immunity
    • 3.7.4 Adaptive Immunity
    • 3.7.5 Spacer Sequences: gRNAs
    • 3.7.6 CRISPR Acts on DNA Targets
    • 3.7.7 Cas9 Cleaves Target DNA
    • 3.7.8 tracrRNA for Cas9 Systems
    • 3.7.9 CRISPR Systems in Other Species
    • 3.7.10 Cas9-Mediated Cleavage
    • 3.7.11 CRISPR-Cas9: Genome Editing
  • 3.8 Market Potential
  • 3.9 Regulatory Framework
    • 3.9.1 U.S. Regulation and Oversight
    • 3.9.2 NIH Guidelines
    • 3.9.3 U.S. FDA
    • 3.9.4 Regulatory Issues
    • 3.9.5 Regulations of Human Germline Edits
    • 3.9.6 Global Regulations
  • 3.10 Porter's Five Forces Analysis of the Market for CRISPR Technology
    • 3.10.1 Bargaining Power of Suppliers: Low
    • 3.10.2 Bargaining Power of Buyers: Moderate
    • 3.10.3 The Threat of Substitutes: Moderate
    • 3.10.4 The Threat of New Entrants: Moderate
    • 3.10.5 The Intensity of Competitive Rivalry: Low
  • 3.11 Scientific Publications
  • 3.12 Patent Analysis
    • 3.12.1 Overview of CRISPR Technology Intellectual Property (IP) and Licensing Structure
  • 3.13 Future of CRISPR
  • 3.14 Market Drivers
    • 3.14.1 CRISPR Versus Chronic Disease
    • 3.14.2 High Prevalence of Genetic Disorders
    • 3.14.3 Government and Private Funding
    • 3.14.4 Increasing Applications of CRISPR
  • 3.15 Market Restraints
    • 3.15.1 Alternative Technologies
    • 3.15.2 Off-target Activity
  • 3.16 Market Challenges
    • 3.16.1 Patent Issues
    • 3.16.2 Risks Associated with CRISPR
    • 3.16.3 R&D
    • 3.16.4 Governmental Policies and Regulations
    • 3.16.5 Bioethical Issues

Chapter 4 Industry Structure

  • 4.1 Commercial Therapeutics
  • 4.2 Correcting Genetic Errors
  • 4.3 Microbes
  • 4.4 Healthier Food

Chapter 5 Impact of COVID-19 on the Market for CRISPR Technology

  • 5.1 Overview

Chapter 6 Competitive Landscape

  • 6.1 Overview
  • 6.2 Competitive Scenario
  • 6.3 Beam Therapeutics
  • 6.4 CRISPR Therapeutics
  • 6.5 Editas Medicine
  • 6.6 Intellia Therapeutics
  • 6.7 Growth Strategies
    • 6.7.1 Licensing and Agreements
    • 6.7.2 Collaborations With Big Biopharmaceutical Companies
    • 6.7.3 Mergers and Acquisitions

Chapter 7 Global Market for CRISPR Technology by End User

  • 7.1 Market Overview
  • 7.2 Market Share and Forecast
  • 7.3 Biotechnology and Pharmaceutical Companies
  • 7.4 Academics and Government Research Institutes
  • 7.5 Contract Research Organizations

Chapter 8 Global Market for CRISPR Technology by Application

  • 8.1 Market Share and Forecast
  • 8.2 Drug Development
  • 8.3 Agriculture
  • 8.4 Diagnostics
    • 8.4.1 Infectious Diseases
    • 8.4.2 Non-infectious diseases
  • 8.5 Clinical Therapy
  • 8.6 Others

Chapter 9 Global Market for CRISPR Technology by Region

  • 9.1 North America
    • 9.1.1 U.S.
    • 9.1.2 Canada
  • 9.2 Europe
    • 9.2.1 Germany
    • 9.2.2 United Kingdom
    • 9.2.3 France
    • 9.2.4 Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 Rest of Asia-Pacific
  • 9.4 Rest of the World

Chapter 10 Company Profiles

  • CARIBOU BIOSCIENCES
  • CRISPR THERAPEUTICS AG
  • DANAHER CORP.
  • EDITAS MEDICINE
  • GENSCRIPT
  • HERA BIOLABS
  • INTELLIA THERAPEUTICS INC.
  • LONZA GROUP LTD.
  • MAMMOTH BIOSCIENCES INC.
  • NEW ENGLAND BIOLABS INC.
  • ORIGENE TECHNOLOGIES
  • PERKINELMER
  • PRECISION BIOSCIENCES
  • SYNTHEGO
  • THERMO FISHER SCIENTIFIC
  • TOOLGEN INC.

List of Tables

  • Summary Table B : Global Market for CRISPR Technology, by Region, Through 2027
  • Summary Table A : Global Market for CRISPR Technology, by End User, Through 2027
  • Table 1 : Comparison of Genome Editing Technologies
  • Table 2 : Selected Monogenic Disease Details
  • Table 3 : CRISPR Applications
  • Table 4 : Global Incidence of Cancer, by Cancer Type/Site, 2020
  • Table 5 : Venture Capitalist Funding, by Company in Gene Editing
  • Table 6 : Bioethical Issues and Risks Associated with CRISPR Technology
  • Table 7 : Selected CAR-T/Gene-Editing Collaborations
  • Table 8 : CRISPR Technology: Competitive Scenario
  • Table 9 : CRISPR Technology: Selected Companies
  • Table 10 : Global Market for CRISPR Technology, by End User, Through 2027
  • Table 11 : Collaborations among Biotechnology and Pharmaceutical CRISPR Technology Companies
  • Table 12 : Global Market for CRISPR Technology in Biotechnology and Pharmaceutical End Uses, by Region, Through 2027
  • Table 13 : Companies Licensing CRISPR Technology from Research Institutions
  • Table 14 : Global Market for CRISPR Technology in Academic and Government Research Institute End Uses, by Region, Through 2027
  • Table 15 : Global Market for CRISPR Technology in Contract Research Organization End Uses, by Region, Through 2027
  • Table 16 : Global Market for CRISPR Technology, by Application, Through 2027
  • Table 17 : Global Market for Drug Development Applications of CRISPR Technology, by Region, Through 2027
  • Table 18 : CRISPR: Edited Crops
  • Table 19 : Global Market for Agriculture-Based Applications of CRISPR Technology, by Region, Through 2027
  • Table 20 : Global Market for Diagnostic Applications of CRISPR Technology, by Region, Through 2027
  • Table 21 : Clinical Trial Using CRISPR Technology for Chronic Disease
  • Table 22 : Global Market for Clinical Therapeutic Applications of CRISPR Technology, by Region, Through 2027
  • Table 23 : Global Market for Other Applications of CRISPR Technology, by Region, Through 2027
  • Table 24 : Global Market for CRISPR Technology, by Region, Through 2027
  • Table 25 : European Market for CRISPR Technology, by Country, Through 2027
  • Table 26 : Asia-Pacific Market for CRISPR Technology, by Country, Through 2027
  • Table 27 : Caribou Biosciences: Product Portfolio
  • Table 28 : Caribou Biosciences: Recent Developments, 2021
  • Table 29 : CRISPR Therapeutics AG: Product Portfolio
  • Table 30 : CRISPR Therapeutics AG: Recent Developments, 2021 and 2022
  • Table 31 : Danaher: Product Portfolio
  • Table 32 : Danaher: Recent Developments, 2020 and 2021
  • Table 33 : Editas Medicine: Product Portfolio
  • Table 34 : Editas Medicine: Recent Developments, 2020-2022
  • Table 35 : GenScript: Product Portfolio
  • Table 36 : GenScript: Recent Developments, 2020 and 2021
  • Table 37 : Hera Biolabs: Product Portfolio
  • Table 38 : Hera Biolabs: Recent Developments, 2020 and 2021
  • Table 39 : Intellia Therapeutics Inc.: Product Portfolio
  • Table 40 : Intellia Therapeutics Inc.: Recent Developments, 2020-2022
  • Table 41 : Lonza Group Ltd.: Product Portfolio
  • Table 42 : Lonza Group Ltd.: Recent Developments, 2020 and 2021
  • Table 43 : Mammoth Biosciences Inc.: Recent Developments, 2020-2022
  • Table 44 : New England Biolabs Inc.: Product Portfolio
  • Table 45 : New England Biolabs Inc.: Recent Developments, 2020 and 2021
  • Table 46 : OriGene Technologies: Product Portfolio
  • Table 47 : PerkinElmer: Product Portfolio
  • Table 48 : PerkinElmer: Recent Developments, 2020 and 2021
  • Table 49 : Precision BioSciences: Product Portfolio
  • Table 50 : Precision BioSciences: Recent Developments, 2020-2022
  • Table 51 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 52 : Thermo Fisher Scientific Inc.: Recent Developments, 2020-2022

List of Figures

  • Summary Figure A : Global Market for CRISPR Technology, by End User, 2019-2027
  • Summary Figure B : Global Market for CRISPR Technology, by Region, 2019-2027
  • Figure 1 : CRISPR Timeline, 2016-2021
  • Figure 2 : Distribution Shares of Scientific Publications on Genome Editing, by Technology, 2018-2021
  • Figure 3 : Distribution of Scientific Publications on Genome Editing, by Year, 2018-2021
  • Figure 4 : Published Patents on CRISPR Technology, 2011-2021
  • Figure 5 : Patent Filings on CRISPR Technology, by Jurisdiction, 2011-2021
  • Figure 6 : Share of Patent Filings on CRISPR Technology, by Applicant, 2011-2021
  • Figure 7 : Global Market Shares of CRISPR Technology, by End User, 2021
  • Figure 8 : Global Market for CRISPR Technology in Biotechnology and Pharmaceutical End Uses, by Region, 2019-2027
  • Figure 9 : Global Market Shares of CRISPR Technology in Biotechnology and Pharmaceutical End Uses, by Region, 2021
  • Figure 10 : Global Market for CRISPR Technology in Academic and Government Research Institute End Uses, by Region, 2019-2027
  • Figure 11 : Global Market Shares of CRISPR Technology in Academic and Government Research Institute End Uses, by Region, 2021
  • Figure 12 : Global Market for CRISPR Technology in Contract Research Organization End Uses, by Region, 2019-2027
  • Figure 13 : Global Market Shares of CRISPR Technology in Contract Research Organization End Uses, by Region, 2021
  • Figure 14 : Global Market Shares of CRISPR Technology, by Application, 2021
  • Figure 15 : CRISPR Technology in Drug Development
  • Figure 16 : CRISPR Technology Usage in Drug Development, by Phase (Commercial)
  • Figure 17 : CRISPR Technology Usage in Drug Development, by Phase (Non-commercial)
  • Figure 18 : Global Market for Drug Development Applications of CRISPR Technology, by Region, 2019-2027
  • Figure 19 : Global Market Shares of Drug Development Applications of CRISPR Technology, by Region, 2021
  • Figure 20 : Global Market for Agriculture-Based Applications of CRISPR Technology, by Region, 2019-2027
  • Figure 21 : Global Market Shares of Agriculture-Based Applications of CRISPR Technology, by Region, 2021
  • Figure 22 : Global Market for Diagnostic Applications of CRISPR Technology, by Region, 2019-2027
  • Figure 23 : Global Market Shares of Diagnostic Applications of CRISPR Technology, by Region, 2021
  • Figure 24 : Global Market for Clinical Therapeutic Applications of CRISPR Technology, by Region, 2019-2027
  • Figure 25 : Global Market Shares of Clinical Therapeutic Applications of CRISPR Technology, by Region, 2021
  • Figure 26 : Global Market for Other Applications of CRISPR Technology, by Region, 2019-2027
  • Figure 27 : Global Market Shares of Other Applications of CRISPR Technology, by Region, 2021
  • Figure 28 : Snapshot of the Global Market for CRISPR Technology
  • Figure 29 : North American Market for CRISPR Technology, 2019-2027
  • Figure 30 : European Market Shares of CRISPR Technology, by Country, 2021
  • Figure 31 : German Market for CRISPR Technology, 2019-2027
  • Figure 32 : U.K. Market for CRISPR Technology, 2019-2027
  • Figure 33 : French Market for CRISPR Technology, 2019-2027
  • Figure 34 : Rest of the European Market for CRISPR Technology, 2019-2027
  • Figure 35 : Asia-Pacific Market Shares of CRISPR Technology, by Country, 2021
  • Figure 36 : Chinese Market for CRISPR Technology, 2019-2027
  • Figure 37 : Japanese Market for CRISPR Technology, 2019-2027
  • Figure 38 : Indian Market for CRISPR Technology, 2019-2027
  • Figure 39 : Rest of Asia-Pacific Market for CRISPR Technology, 2019-2027
  • Figure 40 : RoW Market for CRISPR Technology, 2019-2027
  • Figure 41 : Caribou Biosciences: Annual Revenue, 2019-2021
  • Figure 42 : CRISPR Therapeutics AG: Annual Revenue, 2019-2021
  • Figure 43 : Danaher: Annual Revenue, 2019-2021
  • Figure 44 : Danaher: Market Share, by Region, 2021
  • Figure 45 : Danaher: Market Share, by Business Segment, 2021
  • Figure 46 : Editas Medicine: Annual Revenue, 2019-2021
  • Figure 47 : GenScript: Annual Revenue, 2019-2021
  • Figure 48 : GenScript: Market Share, by Business Segment, 2021
  • Figure 49 : GenScript: Market Share, by Region, 2021
  • Figure 50 : Intellia Therapeutics Inc.: Annual Revenue, 2020 and 2021
  • Figure 51 : Lonza Group Ltd.: Annual Revenue, 2019-2021
  • Figure 52 : Lonza Group Ltd.: Market Share, by Region, 2021
  • Figure 53 : Lonza Group Ltd.: Market Share, by Business Segment, 2021
  • Figure 54 : PerkinElmer: Discovery and Analytical Solutions, Revenue, 2019-2021
  • Figure 55 : PerkinElmer: Market Share, by Business Segment, 2021
  • Figure 56 : PerkinElmer: Market Share, Discovery and Analytical Solutions, by Region, 2021
  • Figure 57 : Precision BioSciences: Annual Revenue, 2019-2021
  • Figure 58 : Precision BioSciences: Market Share, by Business Segment, 2021
  • Figure 59 : Thermo Fisher Scientific Inc.: Annual Revenue, 2019-2021
  • Figure 60 : Thermo Fisher Scientific Inc.: Market Share, by Region, 2021
  • Figure 61 : Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2021